Federation des caisses Desjardins du Quebec’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$604K Buy
10,382
+10,190
+5,307% +$553K ﹤0.01% 1295
2026
Q1
$11.2K Hold
192
﹤0.01% 2291
2025
Q4
$8.86K Buy
192
+86
+81% +$3.85K ﹤0.01% 2296
2025
Q3
$3.82K Hold
106
﹤0.01% 2514
2025
Q2
$3.45K Hold
106
﹤0.01% 2327
2025
Q1
$4K Buy
106
+50
+89% +$4K ﹤0.01% 2220
2024
Q4
$4.58K Hold
56
﹤0.01% 2104
2024
Q3
$6.4K Buy
+56
New +$5.05K ﹤0.01% 2021

Other funds holding PCVX

Federation des caisses Desjardins du Quebec's PCVX Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Vaxcyte (PCVX) stake by 5,307% in Q2 2026, buying an estimated $553K and bringing the position to 10,382 shares worth $604K. The position accounts for ﹤0.01% of the portfolio, ranked #1295.

Federation des caisses Desjardins du Quebec first reported a position in PCVX in Q3 2024 and has held it in 8 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 10,382 shares of Vaxcyte worth $604K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 10,190 Vaxcyte shares in Q2 2026, an estimated $553K.
  • Vaxcyte made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #1295 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Vaxcyte in Q3 2024 and has held it in 8 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.